Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis

AIDS

Volumn 14, Issue 16, 2000, Pages 2467-2473

  Nguyen, Anh T ^a   Gagnon, AnneMarie ^a   Angel, Jonathan B ^a   Sorisky, Alexander ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Adipogenesis; Endocrine; Lipodystrophy; Protease inhibitors; Ritonavir

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; N ACETYLLEUCYLLEUCYLNORLEUCINAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEINASE INHIBITOR; RITONAVIR; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ADIPOCYTES; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; GLYCEROLPHOSPHATE DEHYDROGENASE; HIV PROTEASE INHIBITORS; MICE; RITONAVIR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0033730469     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200011100-00007     Document Type: Article

References (34)

1. HIV protease inhibitors
2. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: A cohort study
3. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women
4. A syndrome of lipoatrophy, lactic acidemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution of protease inhibitor-related lipodystrophy syndrome
5. The fat cell
6. The regulation of adipose tissue distribution in humans
7. Sublines of mouse 3T3 cells that accumulate lipid
8. Understanding adipocyte differentiation
9. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes
10. Organelle relationships in cultured 3T3-L1 preadipocytes
11. Protease inhibitors and adipocyte differentiation in cell culture
12. Development of hormone receptors and hormonal responsiveness in vitro
13. Molecular cloning of mRNA from 3T3 adipocytes: Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development
14. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation
15. SREBP-1, a membrane-bound transcription factor released by sterol-regulated prototeolysis
16. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism
17. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand
18. An inhibitor of HIV-1 protease modulates proteosome activity, antigen presentation, and T cell responses
19. Transcriptional activation of the stearoyl-CoA desaturase 2 gene by sterol regulatory element-binding protein/adipocyte determination and differentiation factor 1
20. The relationship between ritonavir plasma levels and side-effects: Implications for therapeutic drug monitoring
21. Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes: Contribution of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-bisphosphate
22. Adipsin/acylation stimulating protein system in human adipocytes: Regulation of triacylglycerol synthesis
23. Cleavage of structural proteins during assembly of the head of bacteriophage T4
24. Leptin-specific patterns of gene expression in white adipose tissue
25. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
26. Regulating adipogenesis
27. Inhibition of adipocyte differentiation by HIV protease inhibitors
28. HIV protease inhibitors block human preadipocyte differentiation, but not via the PPARγ/RXR heterodimer
29. Regulation of peroxisome proliferator-activated receptor γ expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: Implications for adipocyte differentiation and metabolism
30. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation
31. Human preadipocytes display a depot-specific susceptibility to apoptosis
32. Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes
33. Effect of troglitazone on body fat distribution in type 2 diabetic patients
34. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor